匈牙利布达佩斯消息:美国宾夕法尼亚大学放射学教授Abass Alavi指出,~(111)铟标记的与血栓成分纤维蛋白结合的单克隆抗体“能革新对深部静脉血栓病人的治疗”。 Alavi在1987年欧洲核医学协会代表会议上报告说,对18名怀疑为血栓病人的初步发现表明,追寻纤维蛋白的抗体对血栓定位并指导 Budapest, Hungary: Abass Alavi, a professor of radiology at the University of Pennsylvania in the United States, pointed out that the ~ (111) indium labeled monoclonal antibody that binds fibrin to thrombus components “could revolutionize the treatment of patients with deep vein thrombosis.” Alavi, at a meeting of the European Association of Nuclear Medicine in 1987, reported that preliminary findings on 18 patients suspected of having thrombosis showed that antibodies chasing fibrin targeted and directed thrombosis